Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1

Arany, 1996, An essential role for p300/CBP in the cellular response to hypoxia, Proc. Natl. Acad. Sci. USA, 93, 12969, 10.1073/pnas.93.23.12969 Berra, 2003, HIF prolyl-hydroxylase 2 is the key oxygen sensor setting low steady-state levels of HIF-1α in normoxia, EMBO J., 22, 4082, 10.1093/emboj/cdg392 Christofk, 2008, The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth, Nature, 452, 230, 10.1038/nature06734 David, 2010, HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer, Nature, 463, 364, 10.1038/nature08697 Dombrauckas, 2005, Structural basis for tumor pyruvate kinase M2 allosteric regulation and catalysis, Biochemistry, 44, 9417, 10.1021/bi0474923 Epstein, 2001, C. elegans EGL-9 and mammalian homologs define a family of dioxygenases that regulate HIF by prolyl hydroxylation, Cell, 107, 43, 10.1016/S0092-8674(01)00507-4 Fukuda, 2007, HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cells, Cell, 129, 111, 10.1016/j.cell.2007.01.047 Gatenby, 2004, Why do cancers have high aerobic glycolysis?, Nat. Rev. Cancer, 4, 891, 10.1038/nrc1478 Harris, 2002, Hypoxia—a key regulatory factor in tumour growth, Nat. Rev. Cancer, 2, 38, 10.1038/nrc704 Hitosugi, 2009, Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth, Sci. Signal., 2, ra73, 10.1126/scisignal.2000431 Jiang, 1997, Transactivation and inhibitory domains of hypoxia-inducible factor 1α. Modulation of transcriptional activity by oxygen tension, J. Biol. Chem., 272, 19253, 10.1074/jbc.272.31.19253 Kaelin, 2008, Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway, Mol. Cell, 30, 393, 10.1016/j.molcel.2008.04.009 Köditz, 2007, Oxygen-dependent ATF-4 stability is mediated by the PHD3 oxygen sensor, Blood, 110, 3610, 10.1182/blood-2007-06-094441 Lando, 2002, Asparagine hydroxylation of the HIF transactivation domain a hypoxic switch, Science, 295, 858, 10.1126/science.1068592 Li, 2004, J. Biol. Chem., 279, 55051, 10.1074/jbc.M410287200 Luo, 2010, Hsp70 and CHIP selectively mediate ubiquitination and degradation of hypoxia-inducible factor (HIF)-1α but not HIF-2α, J. Biol. Chem., 285, 3651, 10.1074/jbc.M109.068577 Melillo, 2007, Targeting hypoxia cell signaling for cancer therapy, Cancer Metastasis Rev., 26, 341, 10.1007/s10555-007-9059-x Noguchi, 1986, The M1- and M2-type isozymes of rat pyruvate kinase are produced from the same gene by alternative RNA splicing, J. Biol. Chem., 261, 13807, 10.1016/S0021-9258(18)67091-7 Pescador, 2005, Identification of a functional hypoxia-responsive element that regulates the expression of the egl nine homologue 3 (egln3/phd3) gene, Biochem. J., 390, 189, 10.1042/BJ20042121 Seagroves, 2001, Transcription factor HIF-1 is a necessary mediator of the Pasteur effect in mammalian cells, Mol. Cell. Biol., 21, 3436, 10.1128/MCB.21.10.3436-3444.2001 Semenza, 2003, Targeting HIF-1 for cancer therapy, Nat. Rev. Cancer, 3, 721, 10.1038/nrc1187 Semenza, 2010, Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics, Oncogene, 29, 625, 10.1038/onc.2009.441 Semenza, 1996, Hypoxia response elements in the aldolase A, enolase 1, and lactate dehydrogenase A gene promoters contain essential binding sites for hypoxia-inducible factor 1, J. Biol. Chem., 271, 32529, 10.1074/jbc.271.51.32529 Semenza, 1994, Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1, J. Biol. Chem., 269, 23757, 10.1016/S0021-9258(17)31580-6 Wang, 1995, Hypoxia-inducible factor 1 is a basic-helix-loop-helix-PAS heterodimer regulated by cellular O2 tension, Proc. Natl. Acad. Sci. USA, 92, 5510, 10.1073/pnas.92.12.5510 Wheaton, 2011, Hypoxia regulates cellular metabolism, Am. J. Physiol. Cell Physiol., 300, C385, 10.1152/ajpcell.00485.2010 Xie, 2009, Oxygen-regulated β(2)-adrenergic receptor hydroxylation by EGLN3 and ubiquitylation by pVHL, Sci. Signal., 2, ra33, 10.1126/scisignal.2000444 Zhang, 2008, Digoxin and other cardiac glycosides inhibit HIF-1α synthesis and block tumor growth, Proc. Natl. Acad. Sci. USA, 105, 19579, 10.1073/pnas.0809763105 Kondo, K., Kim, W.Y., Lechpammer, M., and Kaelin, W.G., Jr. (2003). Inhibition of HIF2alpha is sufficient to suppress pVHL-defective tumor growth. PLoS Biol. 1, E83. Krishnamachary, B., Zagzag, D., Nagasawa, H., Rainey, K., Okuyama, H., Baek, J.H., and Semenza, G.L. (2006). Hypoxia-inducible factor-1-dependent repression of E-cadherin in von Hippel-Lindau tumor suppressor-null renal cell carcinoma mediated by TCF3, ZFHX1A, and ZFHX1B. Cancer Res. 66, 2725–2731. Liu, Y.V., Baek, J.H., Zhang, H., Diez, R., Cole, R.N., and Semenza, G.L. (2007). RACK1 competes with HSP90 for binding to HIF-1α and is required for O2-independent and HSP90 inhibitor-induced degradation of HIF-1α. Mol. Cell 25, 207–217. Okuyama, H., Krishnamachary, B., Zhou, Y.F., Nagasawa, H., Bosch-Marce, M., and Semenza, G.L. (2006). Expression of vascular endothelial growth factor receptor 1 in bone marrow-derived mesenchymal cells is dependent on hypoxia-inducible factor 1. J. Biol. Chem. 281, 15554–15563.